Detalhe da pesquisa
1.
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
Breast Cancer Res
; 25(1): 67, 2023 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308971
2.
Using Wearable Technology to Generate Objective Parkinson's Disease Dyskinesia Severity Score: Possibilities for Home Monitoring.
IEEE Trans Neural Syst Rehabil Eng
; 25(10): 1853-1863, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28391201